These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32966770)

  • 61. Therapeutic gene editing, making a point.
    Smits AM
    Cardiovasc Res; 2019 Mar; 115(4):e39-e40. PubMed ID: 30824914
    [No Abstract]   [Full Text] [Related]  

  • 62. Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Gene Editing Technique in Xenotransplantation.
    Naeimi Kararoudi M; Hejazi SS; Elmas E; Hellström M; Naeimi Kararoudi M; Padma AM; Lee D; Dolatshad H
    Front Immunol; 2018; 9():1711. PubMed ID: 30233563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CRISPR-Cas9 therapies in experimental mouse models of cancer.
    Estêvão D; Rios Costa N; da Costa RG; Medeiros R
    Future Oncol; 2018 Aug; 14(20):2083-2095. PubMed ID: 30027767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
    Xu R; Wei P; Yang J
    Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Next-generation diagnostics with CRISPR.
    Chertow DS
    Science; 2018 Apr; 360(6387):381-382. PubMed ID: 29700254
    [No Abstract]   [Full Text] [Related]  

  • 66. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.
    Ebrahimi S; Teimoori A; Khanbabaei H; Tabasi M
    Rev Med Virol; 2019 Jan; 29(1):e2009. PubMed ID: 30260068
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Inhibiting CRISPR.
    Rusk N
    Nat Methods; 2019 Mar; 16(3):218. PubMed ID: 30814697
    [No Abstract]   [Full Text] [Related]  

  • 68. Immunity to Cas9 as an Obstacle to Persistent Genome Editing.
    Gough V; Gersbach CA
    Mol Ther; 2020 Jun; 28(6):1389-1391. PubMed ID: 32428441
    [No Abstract]   [Full Text] [Related]  

  • 69. Towards precise, safe genome editing.
    Memczak S; Shao Y; Izpisua Belmonte JC
    Cell Res; 2019 Sep; 29(9):687-689. PubMed ID: 31201381
    [No Abstract]   [Full Text] [Related]  

  • 70. Taking CRISPR to New Heights.
    Barrangou R
    CRISPR J; 2019 Jun; 2():133. PubMed ID: 31225750
    [No Abstract]   [Full Text] [Related]  

  • 71. [CRISPR/Cas-based genome editing in Aspergillus niger].
    Zheng X; Zheng P; Sun J
    Sheng Wu Gong Cheng Xue Bao; 2021 Mar; 37(3):980-990. PubMed ID: 33783162
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Designer nanocarriers for navigating the systemic delivery of oncolytic viruses.
    Howard F; Muthana M
    Nanomedicine (Lond); 2020 Jan; 15(1):93-110. PubMed ID: 31868115
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CRISPR inhibitors.
    Rusk N
    Nat Methods; 2019 Jul; 16(7):577. PubMed ID: 31249419
    [No Abstract]   [Full Text] [Related]  

  • 74. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
    Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
    Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
    [No Abstract]   [Full Text] [Related]  

  • 75. Applications of CRISPR systems in respiratory health: Entering a new 'red pen' era in genome editing.
    Moses C; Kaur P
    Respirology; 2019 Jul; 24(7):628-637. PubMed ID: 30883991
    [TBL] [Abstract][Full Text] [Related]  

  • 76. E Pluribus Unum ("Out of Many, One"): CRISPR Modeling of Myeloid Expansion.
    Shin J; Corn JE
    Cell Stem Cell; 2017 Oct; 21(4):415-416. PubMed ID: 28985519
    [TBL] [Abstract][Full Text] [Related]  

  • 77. CRISPR-Edited Immune Effectors: The End of the Beginning.
    Mo F; Heslop HE; Mamonkin M
    Mol Ther; 2020 Apr; 28(4):995-996. PubMed ID: 32203679
    [No Abstract]   [Full Text] [Related]  

  • 78. CRISPR-based diagnostics.
    Stower H
    Nat Med; 2018 Jun; 24(6):702. PubMed ID: 29875459
    [No Abstract]   [Full Text] [Related]  

  • 79. Bringing CRISPR to the Cinema.
    Barrangou R
    CRISPR J; 2019 Aug; 2():187. PubMed ID: 31436507
    [No Abstract]   [Full Text] [Related]  

  • 80. Thinking About CRISPR: The Ethics of Human Genome Editing.
    Barrangou R
    CRISPR J; 2019 Oct; 2(5):247-248. PubMed ID: 31599676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.